Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced a proposal to acquire all of the outstanding shares of Mylan N.V. (Nasdaq ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Guidance Hot Corp. News Hot M&A Management Comments Mergers and Acquisitions Trader Talk

Stifel Downgrades Perrigo Co. (PRGO) to HoldApril 21, 2015 1:34 PM BMO Capital Upgrades Mylan (MYL) to Market PerformApril 21, 2015 12:52 PM Teva Pharma (TEVA) Needs to Raise Mylan (MYL) Bid to $85-$88/Share, Leerink Partners SaysApril 21, 2015 12:10 PM Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and StockApril 21, 2015 8:45 AM Teva (TEVA) May Approach Mylan (MYL) as Soon as Tuesday - BloombergApril 21, 2015 6:37 AM Teva Pharma (TEVA) Doesn't Need Mega Deal: Deutsche Bank (MYL)April 20, 2015 9:10 AM Teva (TEVA) Said Considering Bid for Mylan (MYL)April 17, 2015 2:21 PM